Bone Marrow Transplantation in Treating Patients With Leukemia, Myelodysplasia, or Lymphoblastic Lymphoma - Related Studies

Bone Marrow Transplantation in Treating Patients With Leukemia, Myelodysplasia, or Lymphoblastic Lymphoma

This study is ongoing, but not recruiting participants.

Study NCT00003187. Last updated on July 23, 2008. Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Leukemia
		Lymphoma
		Myelodysplastic Syndromes

2	Additional conditions recognized in this trial
		Precursor Cell Lymphoblastic Leukemia-Lymphoma
		Preleukemia
		Syndrome

3	More general conditions related to this trial
		Bone Marrow Diseases
		Disease
		Hematologic Diseases
		Immune System Diseases
		Immunoproliferative Disorders
		Leukemia, Lymphoid
		Lymphatic Diseases
		Lymphoproliferative Disorders
		Neoplasms
		Neoplasms by Histologic Type
		Pathologic Processes
		Precancerous Conditions

4	Interventions listed in this trial
		cyclophosphamide
		cyclosporine
		cytarabine
		filgrastim
		methotrexate
		methylprednisolone
		radiation therapy

5	Additional drug interventions recognized in this trial
		Cyclosporins
		Methylprednisolone acetate
		Methylprednisolone Hemisuccinate
		Prednisolone
		Prednisolone acetate

6	More general drug interventions related to this trial
		Abortifacient Agents
		Abortifacient Agents, Nonsteroidal
		Alkylating Agents
		Anti-Infective Agents
		Anti-Inflammatory Agents
		Antiemetics
		Antifungal Agents
		Antimetabolites
		Antimetabolites, Antineoplastic
		Antineoplastic Agents
		Antineoplastic Agents, Alkylating
		Antineoplastic Agents, Hormonal
		Antirheumatic Agents
		Antiviral Agents
		Autonomic Agents
		Central Nervous System Agents
		Dermatologic Agents
		Enzyme Inhibitors
		Folic Acid Antagonists
		Gastrointestinal Agents
		Glucocorticoids
		Hormones
		Hormones, Hormone Substitutes, and Hormone Antagonists
		Immunologic Factors
		Immunosuppressive Agents
		Molecular Mechanisms of Pharmacological Action
		Myeloablative Agonists
		Neuroprotective Agents
		Nucleic Acid Synthesis Inhibitors
		Peripheral Nervous System Agents
		Pharmacologic Actions
		Physiological Effects of Drugs
		Protective Agents
		Reproductive Control Agents
		Therapeutic Uses

7	Sponsors listed in this trial
		Massey Cancer Center
		National Cancer Institute (NCI)